自2019年底SARS-CoV-2开始感染人群以来,其中一些人患有严重肺炎(约5%),这可能是致命的(病死率~3.5%),COVID-19爆发的程度和速度是惊人的。在2.5个月内(到2020年3月18日),在161个国家/地区确定了超过191,127名COVID-19患者。到那时,在中国,超过700名儿科患者被证实患有COVID-19,在其他地方只有大约58人被诊断出来。到现在为止,有成千上万的儿童和青少年被感染。中国儿科医生希望分享他们在中国如何管理这些患者的经验,以及指导他们应对不断变化的挑战的关键建议。中国儿科学会和《中华儿科杂志》编辑委员会召集了一组专家,从对中国确诊的COVID-19儿科患者的调查中提取了信息数据。诊断共识,管理,儿科COVID-19的预防是根据对这些数据的分析以及从过去SARS和MERS冠状病毒爆发中获得的见解制定的。来自管理成年患者的医生的相关累积经验,关于临床和科学COVID-19和SARS-CoV-2数据的快速报告,和国家卫生委员会关于COVID-19管理的指南被纳入本提案.
Ever since SARS-CoV-2 began infecting people by the end of 2019, of whom some developed severe pneumonia (about 5%), which could be fatal (case fatality ~3.5%), the extent and speed of the COVID-19 outbreak has been phenomenal. Within 2.5 months (by March 18, 2020) over 191,127 COVID-19 patients have been identified in 161 countries. By then, over 700 pediatric patients were confirmed to have COVID-19 in
China, with only about 58 diagnosed elsewhere. By now, there are thousands of children and adolescents infected. Chinese pediatricians would like to share their experience on how these patients were managed in
China and the key recommendations that had guided them in meeting the evolving challenges. A group of experts were summoned by the Chinese Pediatric Society and Editorial Board of Chinese Journal of Pediatrics to extract informative data from a survey on confirmed COVID-19 pediatric patients in
China. Consensus on diagnosis, management, and prevention of pediatric COVID-19 were drawn up based on the analysis of such data plus insights gained from the past SARS and MERS coronavirus outbreaks. Relevant cumulating experiences from physicians managing adult patients, expedited reports on clinical and scientific COVID-19 and SARS-CoV-2 data, and the National Health Committee guidelines on COVID-19 management were integrated into this proposal.